Eye birth defect study from newborns to adults
Part of Eyes & vision, Genetic & congenital clinical trials.
This is a national study that follows people with certain rare eye birth defects and their families, including pregnant people. It aims to better understand how often related health issues happen and to study inheritance (DNA) in families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these eye conditions: anophthalmia, microphthalmia, aniridia, or an underdeveloped front part of the eye
- If you’re a child: you must be from birth up to age 7, or age 8 and older with the eye defect
- If you’re an adult: you must have one of the listed eye conditions
- You (or a parent/guardian) can understand the study and agree to join by signing informed consent
- If your child has the eye condition: you may be asked to join for the family inheritance (DNA) part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic causes of rare eye conditions (microphthalmia, anophthalmia, and coloboma). It helps researchers understand why these conditions happen and how they run in families.
This study collects DNA samples and medical information from people with rare inherited eye diseases and their close relatives. The goal is to learn more about the genetic causes of these conditions and improve diagnosis and care.
This study looks at how genes may cause certain eye conditions called microphthalmia, anophthalmia, and uveal coloboma. You may qualify if you have one of these conditions or are a close, unaffected relative who could also carry the gene.
This study looks for biological markers in the blood or eye samples of people with rare eye diseases compared to healthy volunteers. It aims to better understand and diagnose these conditions.
This trial collects information from people born with congenital aniridia (a rare eye condition) using a questionnaire or survey. It may help researchers better understand patient needs and experiences to improve future care.
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
Hear when a new Anophthalmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.